Olin Corp tiene un precio objetivo de consenso de $32.44 basado en las calificaciones de 18 analistas. El máximo es $75, emitido por Piper Sandler el abril 29, 2024. El mínimo es $20, emitido por Morgan Stanley el mayo 12, 2025. Las 3 calificaciones de analistas más recientes fueron publicadas por UBS, Truist Securities y Wells Fargo el octubre 29, 2025, respectivamente. Con un precio objetivo promedio de $21.67 entre UBS, Truist Securities y Wells Fargo, hay una 11.45% upside implícita para Olin Corp según estas calificaciones más recientes de analistas.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/29/2025 | 13.17% | UBS | $24 → $22 | Maintains | Neutral | |||
10/29/2025 | 8.02% | Truist Securities | $22 → $21 | Maintains | Hold | |||
10/29/2025 | 13.17% | Wells Fargo | $25 → $22 | Maintains | Equal-Weight | |||
10/29/2025 | 49.18% | Keybanc | $30 → $29 | Maintains | Overweight | |||
10/14/2025 | 54.32% | B of A Securities | $25 → $30 | Maintains | Buy | |||
10/07/2025 | 28.6% | Wells Fargo | $21 → $25 | Maintains | Equal-Weight | |||
10/06/2025 | 23.46% | UBS | $21 → $24 | Maintains | Neutral | |||
10/02/2025 | 28.6% | Citigroup | $25 → $25 | Downgrade | Buy → Neutral | |||
07/31/2025 | 8.02% | UBS | $22 → $21 | Maintains | Neutral | |||
07/30/2025 | 8.02% | Wells Fargo | $22 → $21 | Maintains | Equal-Weight | |||
07/30/2025 | 59.47% | Keybanc | $32 → $31 | Maintains | Overweight | |||
07/29/2025 | 13.17% | UBS | $23 → $22 | Maintains | Neutral | |||
07/29/2025 | 18.31% | Mizuho | $24 → $23 | Maintains | Neutral | |||
07/15/2025 | 23.46% | Mizuho | $25 → $24 | Maintains | Neutral | |||
07/14/2025 | 64.61% | Keybanc | $34 → $32 | Maintains | Overweight | |||
07/09/2025 | 18.31% | UBS | $22 → $23 | Maintains | Neutral | |||
07/08/2025 | 28.6% | Citigroup | $26 → $25 | Maintains | Buy | |||
07/03/2025 | 18.31% | RBC Capital | $25 → $23 | Maintains | Sector Perform | |||
05/28/2025 | 23.46% | Barclays | $28 → $24 | Maintains | Equal-Weight | |||
05/12/2025 | 2.88% | Morgan Stanley | $28 → $20 | Maintains | Underweight | |||
05/06/2025 | 28.6% | Goldman Sachs | $33 → $25 | Maintains | Neutral | |||
05/06/2025 | 2.88% | JP Morgan | $28 → $20 | Maintains | Neutral | |||
05/06/2025 | 13.17% | Wells Fargo | $19 → $22 | Maintains | Equal-Weight | |||
05/05/2025 | 23.46% | Truist Securities | $25 → $24 | Maintains | Hold | |||
05/05/2025 | 28.6% | RBC Capital | $28 → $25 | Maintains | Sector Perform | |||
05/02/2025 | 13.17% | UBS | $21 → $22 | Maintains | Neutral | |||
04/14/2025 | 74.9% | Keybanc | $40 → $34 | Maintains | Overweight | |||
04/14/2025 | 28.6% | Truist Securities | $32 → $25 | Maintains | Hold | |||
04/09/2025 | -2.26% | Wells Fargo | $25 → $19 | Maintains | Equal-Weight | |||
04/07/2025 | 8.02% | UBS | $34 → $21 | Maintains | Neutral | |||
04/07/2025 | 33.74% | Piper Sandler | $33 → $26 | Maintains | Neutral | |||
04/01/2025 | 28.6% | Wells Fargo | $31 → $25 | Maintains | Equal-Weight | |||
04/01/2025 | 44.03% | Barclays | $34 → $28 | Maintains | Equal-Weight | |||
03/27/2025 | 54.32% | Citigroup | $34 → $30 | Maintains | Buy | |||
02/27/2025 | 44.03% | JP Morgan | $50 → $28 | Downgrade | Overweight → Neutral | |||
02/13/2025 | 69.75% | Piper Sandler | $41 → $33 | Downgrade | Overweight → Neutral | |||
02/05/2025 | 74.9% | BMO Capital | $44 → $34 | Maintains | Market Perform | |||
02/04/2025 | 54.32% | RBC Capital | $45 → $30 | Downgrade | Outperform → Sector Perform | |||
02/04/2025 | 44.03% | Morgan Stanley | $31 → $28 | Maintains | Underweight | |||
02/03/2025 | 74.9% | Barclays | $43 → $34 | Maintains | Equal-Weight | |||
02/03/2025 | 64.61% | Truist Securities | $38 → $32 | Maintains | Hold | |||
02/03/2025 | 59.47% | Wells Fargo | $40 → $31 | Maintains | Equal-Weight | |||
02/03/2025 | 105.76% | Keybanc | $50 → $40 | Maintains | Overweight | |||
01/31/2025 | 74.9% | UBS | $35 → $34 | Maintains | Neutral | |||
01/28/2025 | 95.47% | Truist Securities | → $38 | Initiates | → Hold | |||
01/16/2025 | 131.48% | RBC Capital | $48 → $45 | Maintains | Outperform | |||
01/14/2025 | 105.76% | B of A Securities | $48 → $40 | Upgrade | Neutral → Buy | |||
01/13/2025 | 59.47% | Morgan Stanley | $41 → $31 | Maintains | Underweight | |||
01/10/2025 | 80.04% | UBS | $48 → $35 | Maintains | Neutral | |||
01/10/2025 | 157.2% | Keybanc | $56 → $50 | Maintains | Overweight | |||
01/07/2025 | 110.91% | Piper Sandler | $51 → $41 | Maintains | Overweight | |||
12/16/2024 | 131.48% | Citigroup | $48 → $45 | Maintains | Buy | |||
12/13/2024 | 121.19% | Barclays | $45 → $43 | Maintains | Equal-Weight | |||
10/30/2024 | 162.35% | Piper Sandler | $57 → $51 | Maintains | Overweight | |||
10/29/2024 | 141.77% | BMO Capital | $50 → $47 | Maintains | Market Perform | |||
10/29/2024 | 146.91% | RBC Capital | $52 → $48 | Maintains | Outperform | |||
10/28/2024 | 126.34% | Wells Fargo | $48 → $44 | Maintains | Equal-Weight | |||
10/28/2024 | 131.48% | Barclays | $49 → $45 | Maintains | Equal-Weight | |||
10/28/2024 | 188.07% | Keybanc | $57 → $56 | Maintains | Overweight | |||
10/25/2024 | 146.91% | UBS | $52 → $48 | Maintains | Neutral | |||
10/07/2024 | 167.49% | UBS | $49 → $52 | Maintains | Neutral | |||
10/07/2024 | 193.21% | Keybanc | $62 → $57 | Maintains | Overweight | |||
09/03/2024 | 157.2% | BMO Capital | → $50 | Initiates | → Market Perform | |||
08/08/2024 | 131.48% | Mizuho | → $45 | Initiates | → Neutral | |||
07/30/2024 | 193.21% | Piper Sandler | $75 → $57 | Maintains | Overweight | |||
07/29/2024 | 162.35% | B of A Securities | $62 → $51 | Downgrade | Buy → Neutral | |||
07/29/2024 | 146.91% | Deutsche Bank | $57 → $48 | Maintains | Hold | |||
07/29/2024 | 218.93% | Keybanc | $69 → $62 | Maintains | Overweight | |||
07/29/2024 | 152.06% | Barclays | $59 → $49 | Maintains | Equal-Weight | |||
07/29/2024 | 152.06% | Goldman Sachs | $55 → $49 | Maintains | Neutral | |||
07/29/2024 | 167.49% | RBC Capital | $61 → $52 | Maintains | Outperform | |||
07/29/2024 | 146.91% | Wells Fargo | $50 → $48 | Maintains | Equal-Weight | |||
07/29/2024 | 182.92% | JP Morgan | → $55 | Upgrade | Neutral → Overweight | |||
07/26/2024 | 152.06% | UBS | $51 → $49 | Maintains | Neutral | |||
07/10/2024 | 254.94% | Keybanc | $73 → $69 | Maintains | Overweight | |||
07/09/2024 | 162.35% | UBS | $59 → $51 | Maintains | Neutral | |||
04/29/2024 | 224.07% | RBC Capital | $69 → $63 | Maintains | Outperform | |||
04/29/2024 | 254.94% | Stifel | $68 → $69 | Maintains | Buy | |||
04/29/2024 | 270.37% | B of A Securities | $74 → $72 | Maintains | Buy | |||
04/29/2024 | 285.8% | Piper Sandler | $72 → $75 | Maintains | Overweight | |||
04/29/2024 | 275.51% | Keybanc | $78 → $73 | Maintains | Overweight | |||
04/19/2024 | 254.94% | RBC Capital | $64 → $69 | Maintains | Outperform | |||
04/10/2024 | 244.65% | Citigroup | $63 → $67 | Maintains | Buy | |||
04/09/2024 | 301.23% | Keybanc | $66 → $78 | Maintains | Overweight | |||
04/04/2024 | 203.5% | Barclays | $57 → $59 | Maintains | Equal-Weight | |||
04/03/2024 | 208.64% | Wells Fargo | $56 → $60 | Maintains | Equal-Weight | |||
01/31/2024 | 213.79% | Goldman Sachs | $55 → $61 | Maintains | Neutral | |||
01/30/2024 | 213.79% | Goldman Sachs | $55 → $61 | Maintains | Neutral | |||
01/29/2024 | 229.22% | RBC Capital | $58 → $64 | Maintains | Outperform | |||
01/29/2024 | 193.21% | Barclays | $49 → $57 | Maintains | Equal-Weight | |||
01/29/2024 | 239.51% | Stifel | $65 → $66 | Maintains | Buy | |||
01/26/2024 | 198.35% | UBS | $56 → $58 | Maintains | Neutral | |||
01/11/2024 | 188.07% | UBS | $53 → $56 | Maintains | Neutral | |||
01/09/2024 | 239.51% | Keybanc | $61 → $66 | Maintains | Overweight | |||
12/14/2023 | 182.92% | Goldman Sachs | $50 → $55 | Maintains | Neutral | |||
12/07/2023 | 167.49% | Deutsche Bank | → $52 | Initiates | → Hold | |||
11/13/2023 | 157.2% | Citigroup | → $50 | Initiates | → Buy | |||
10/31/2023 | 157.2% | Goldman Sachs | $57 → $50 | Maintains | Neutral | |||
10/30/2023 | 146.91% | Fermium Research | $54 → $48 | Maintains | Hold | |||
10/30/2023 | 234.36% | Stifel | $66 → $65 | Maintains | Buy |
El último precio objetivo de Olin (NYSE:OLN) fue comunicado por UBS el octubre 29, 2025. La firma de analistas fijó un precio objetivo para $22.00 que espera OLN a rise dentro de 12 meses (un posible 13.17% upside). 53 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Olin (NYSE:OLN) fue proporcionada por UBS, y Olin mantuvo su neutral calificación.
La última revisión al alza de Olin Corp se produjo en enero 14, 2025, cuando B of A Securities elevó su precio objetivo a $40. B of A Securities anteriormente tenía a neutral para Olin Corp.
La última revisión a la baja de Olin Corp se produjo en octubre 2, 2025, cuando Citigroup cambió su precio objetivo de $25 a $25 para Olin Corp.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Olin, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Olin se registró el octubre 29, 2025, por lo que la próxima calificación estará disponible en torno al octubre 29, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Olin (OLN) fue un mantuvo con un precio objetivo de $24.00 a $22.00. El precio actual al que cotiza Olin (OLN) es de $19.44, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.